Weed Play $PIHN to Plant Hemp Seed on Kentucky
Post# of 47147
Posted On: 05/04/2014 7:52:33 PM
Weed Play
$PIHN to Plant Hemp Seed on Kentucky Farm!
PLANO, TX--(Marketwired - May 1, 2014) - Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) has purchased over 2,000 lbs of hemp seed to plant on the 70 acre farm in Kentucky. The Company plans on planting the seeds on May 24 and 25, 2014, with the help of several area Military Veterans. This event should receive significant media coverage throughout the area.
The hemp seed being planted is to be used for the production of The Company's ProCannas line of products. This will help the Company with both cost and quality control of hemp being used in the ProCannas products. Tentative plans for extraction of the CBDs from the growth production will be completed within Kentucky which will decrease delivery and production time.
"We are excited to start growing our own brand of hemp products. We can control the quality and precision of the products coming from our own fields. This gives us a competitive advantage over our competitors," states Medical Director, Dr. Vasthi Alvarez Avila.
ABOUT THE COMPANY
Polaris International Holdings, Inc.'s line ProCannas focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use. With the Joint Venture 70 acre hemp farm in Kentucky, the Company will grow and develop a large portion of its own hemp products. Due to the concentrated strength and unique mix of ingredients integrated within our products, they are intended to be available to patients only through licensed participating physicians. Due to recent changes in the law regarding the medical use of marijuana, coupled with studies and a strong body of evidence highlighting that THC is not the significant component for medicinal use, doors are opening for innovation. Laws are expected to become even more favorable for companies like ProCannas. The Company intends to target a broad range of specialties with this novel product, including but not limited to sports medicine, pain management, neurology, and osteopathic medicine.
$PIHN to Plant Hemp Seed on Kentucky Farm!
PLANO, TX--(Marketwired - May 1, 2014) - Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) has purchased over 2,000 lbs of hemp seed to plant on the 70 acre farm in Kentucky. The Company plans on planting the seeds on May 24 and 25, 2014, with the help of several area Military Veterans. This event should receive significant media coverage throughout the area.
The hemp seed being planted is to be used for the production of The Company's ProCannas line of products. This will help the Company with both cost and quality control of hemp being used in the ProCannas products. Tentative plans for extraction of the CBDs from the growth production will be completed within Kentucky which will decrease delivery and production time.
"We are excited to start growing our own brand of hemp products. We can control the quality and precision of the products coming from our own fields. This gives us a competitive advantage over our competitors," states Medical Director, Dr. Vasthi Alvarez Avila.
ABOUT THE COMPANY
Polaris International Holdings, Inc.'s line ProCannas focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use. With the Joint Venture 70 acre hemp farm in Kentucky, the Company will grow and develop a large portion of its own hemp products. Due to the concentrated strength and unique mix of ingredients integrated within our products, they are intended to be available to patients only through licensed participating physicians. Due to recent changes in the law regarding the medical use of marijuana, coupled with studies and a strong body of evidence highlighting that THC is not the significant component for medicinal use, doors are opening for innovation. Laws are expected to become even more favorable for companies like ProCannas. The Company intends to target a broad range of specialties with this novel product, including but not limited to sports medicine, pain management, neurology, and osteopathic medicine.
(0)
(0)